Parnell Pharmaceuticals Holdings ROA 2014-2018 | PARNF
Current and historical return on assets (ROA) values for Parnell Pharmaceuticals Holdings (PARNF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Parnell Pharmaceuticals Holdings ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2018-03-31 |
$-0.01B |
$0.02B |
-25.23% |
| 2016-12-31 |
$-0.02B |
$0.04B |
-60.00% |
| 2016-09-30 |
$-0.02B |
$0.03B |
-56.60% |
| 2015-12-31 |
$-0.01B |
$0.04B |
-52.63% |
| 2015-09-30 |
$0.00B |
$0.00B |
-19.51% |
| 2015-06-30 |
$0.00B |
$0.04B |
-14.63% |
| 2014-12-31 |
$-0.01B |
$0.04B |
-20.34% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
